Shilpa Medicare is currently trading at Rs. 418.65, up by 35.15 points or 9.17% from its previous closing of Rs. 383.50 on the BSE.
The scrip opened at Rs. 399.00 and has touched a high and low of Rs. 433.90 and Rs. 392.10 respectively. So far 46804 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 1 has touched a 52 week high of Rs. 708.80 on 11-Jul-2017 and a 52 week low of Rs. 374.10 on 05-Jun-2018.
Last one week high and low of the scrip stood at Rs. 433.90 and Rs. 375.00 respectively. The current market cap of the company is Rs. 3452.66 crore.
The promoters holding in the company stood at 53.80%, while Institutions and Non-Institutions held 31.91% and 14.29% respectively.
Shilpa Medicare has received EIR (Establishment Inspection Report) from US Food and Drug Administration (USFDA) to both API manufacturing facilities located at Raichur, Karnataka. This inspection was carried out on January 16-19, 2018. The inspection has now been closed by USFDA.
Shilpa Medicare produces and exports consistently high-quality Active Pharmaceutical Ingredients Fine Chemicals, intermediates, herbal products and speciality chemical products using sophisticated technology, meticulously following international specifications.
